This inventor holds 4 USPTO granted patents and 4 published patent applications and 4 EPO patents. Top assignee: Orion Corporation. Active years: 2002-2026.
Company Filing History:
Years Active: 2002-2026
Title: Jukka Salmia: Innovator in Pharmaceutical Compositions
Introduction
Jukka Salmia is a notable inventor based in Kuusisto, Finland. He has made significant contributions to the field of pharmaceutical compositions, particularly focusing on triphenylethylene antiestrogens. With a total of 4 patents to his name, Salmia's work has the potential to impact medical treatments significantly.
Latest Patents
Salmia's latest patents include innovative aqueous compositions of nonsteroidal triphenylethylene antiestrogens for pharmaceutical use. These compositions utilize a solubility-enhancing agent, which is a pharmaceutically acceptable mono- or dicarboxylic acid with 1-5 carbon atoms. The carbon chain may also contain hydroxyl, oxo, or halogen substituents, or a corresponding anion, along with methanesulfonic acid or its anion. Additionally, these compositions may include organic water-miscible co-solvents such as polyethylene glycol (PEG), propylene glycol, ethanol, or isopropanol.
Career Highlights
Jukka Salmia is currently associated with Orion Corporation, where he continues to develop his innovative ideas in pharmaceutical formulations. His work is characterized by a commitment to enhancing the solubility and efficacy of antiestrogen compounds, which are crucial in various therapeutic applications.
Collaborations
Salmia has collaborated with esteemed colleagues, including Kaija Af Ursin and Heikki Niskanen. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in their respective fields.
Conclusion
Jukka Salmia's contributions to pharmaceutical innovations, particularly in the area of triphenylethylene antiestrogens, highlight his role as a significant inventor. His work continues to pave the way for advancements in medical treatments and pharmaceutical applications.